Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...

AUSTIN, Texas, Nov. 4, 2024 /PRNewswire/ -- Flex (NASDAQ: FLEX) today announced it received Cisco's 2024 Excellence in ESG (Environmental, Social, and Governance) award. Cisco presented this ...

Flex (FLEX) said the company now expects fiscal 2025 revenue in a range of $24.9 billion to $25.5 billion, GAAP EPS of $1.77 to $1.89, and adjusted EPS in a range of $2.39 to $2.51. In July, the ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Leader in custom-engineered, fully integrated power distribution and protection systems Extensive modular solutions and medium voltage switchgear capabilities are synergistic to the Flex data ...

Will the new U16 Flex live up to the game-changing U12 Vesla? Let's find out. The Ultenic U16 Flex has an RRP of £199.99/$159.99 and can be purchased from Ultenic or Amazon. If you decide the U16 ...

To supplement Flex's unaudited selected financial data presented consistent with U.S. Generally Accepted Accounting Principles ("GAAP"), the Company discloses certain non-GAAP financial measures ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals Boehringer Ingelheim shared earlier this month that it has officially opened the ...